Moderna seeks regulatory nod for COVID vaccine in very young children and WHO reports second straight week of cases rising globally

Moderna Inc. will seek an emergency use authorization from regulators in the U.S., Europe and elsewhere for its COVID-19 vaccine in babies, toddlers and preschoolers, after a late-stage trial found it produced virus-fighting antibodies that were just as strong as in young adults.